Cello Health PLC - Result of AGM

RNS Number : 5097N

Cello Health PLC

20 May 2020

Cello Health plc

("Cello" or the "Company")

Result of AGM

Cello Health plc (AIM: CLL), the global healthcare-focused advisory group, held its Annual General Meeting ("AGM") earlier today at which all resolutions were duly passed.

The votes were as follows:

Resolution	Votes FOR	Votes AGAINST	Votes withheld*

1. Approve the Report & Accounts	72,550,306	-	-

2. Approve the Remuneration Report	72,515,136	17,698	14,472

3. Re-elect Chris Jones	72,531,418	10,000	1,888

4. Re-elect Mark Bentley	72,531,418	10,000	1,888

5. Re-elect Stephen Highley	72,524,418	10,000	1,888

6. Re-appoint auditors	72,210,784	10,000	329,849

7. Section 551 authority	72,444,245	102,500	3,888

8. Section 570 authority	70,879,962	1,628,527	42,144

9. Section 701 authority	70,866,841	24,000	1,657,788

* Please note that a vote withheld is not a vote in law.

Enquiries

Cello Health	020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance Director

Cenkos Securities	020 7397 8900
Giles Balleny
Harry Hargreaves

Buchanan	020 7466 5000
Mark Court
Jamie Hooper
Charlotte Slater

Notes to Editors

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading scientific, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

Cello Health plc enables clients to commercialise, differentiate their assets, and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia, New Jersey, London, Edinburgh, and Farnham.

For further information, please visit: https://cellohealthplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGEAASEAELEEFA

Quick facts: Cello Health PLC

Price: 162.5

Market: AIM

Market Cap: £173.37 m

Follow

View company profile

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE